Novel Approaches to Postoperative Chemoradiation Therapy in Pancreatic Cancer

Journal of Gastrointestinal Surgery

Volumn 5, Issue 1, 2001, Pages 8-9

  Picozzi, Vincent J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE; RADIOSENSITIZING AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; HUMAN; MORTALITY; PANCREAS TUMOR; PANCREATICODUODENECTOMY; REVIEW; SURVIVAL; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035223045     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80004-4     Document Type: Article

References (8)

1. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. Ann Surg 1997; 225:621-626.
2. Kaiser MH, Ellenberg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
3. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection for pancreas cancer. Cancer 1987; 59:2006-2010.
4. Whittington R, Bryer M, Haller D, et al. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-1143.
5. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-489.
6. Klinkenbijl J, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg 1999;230:776-784.
7. Picozzi V, Kozarek R, Rieke J, et al. Adjuvant, combined modality therapy for resected, high-risk adenocarcinoma of the pancreas using cisplatin, 5FU and alpha-interferon as radiosensitizers: A phase II study [abstr]. Proc Am Soc Clin Oncol 1999;18:260a.
8. Nukui Y, Picozzi V, Traverso L. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (in press).